Monday, October 26, 2026
The top medical stories of the day, as they ran.
Morning edition
7 stories
- 1Moderna and Merck report melanoma vaccine cut recurrence or death risk by 42%Research · 4 outlets
- 2FDA approves once-weekly insulin for children with type 2 diabetesDrugs and FDA · 3 outlets
- 3Durvalumab and enfortumab vedotin improved outcomes in bladder cancer trialResearch · 2 outlets
- 4House panel investigates PBMs over claims of retaliation through pharmacy auditsHealth policy · 2 outlets
- 5Tonight We Ride, LLC Issues Voluntary Recall of Ultimate Forza Male Supplement Due to Presence of Undeclared Sildenafil, Tadalafil, and DapoxetineDrug safety · 1 outlet
- 6FDA warns consumers not to use Ultra Bon over hidden diclofenacDrug safety · 1 outlet
- 7Death reported in Bristol Myers Squibb multiple sclerosis CAR-T studyResearch · 2 outlets
Evening edition
10 stories
- 1Trial finds Merck and Moderna melanoma vaccine cut recurrence or death risk by 42%Research · 5 outlets
- 2Four medical societies issue framework for girls’ and women’s heart healthHeart health · 4 outlets
- 3Roche's divarasib improved survival in previously treated KRAS G12C lung cancerResearch · 3 outlets
- 4Consultants in England announce two-day strike over pay and conditionsHospitals · 3 outlets
- 5Uganda tightens Ebola border controls and requires quarantine for returneesInfectious disease · 1 outlet
- 6HHS finalizes rule easing health IT certification and security requirementsHealth policy · 2 outlets
- 7Bon Secours Mercy Health agrees to acquire Surgery Partners in $5.7 billion dealIndustry · 3 outlets
- 8More than 250 hospitals pledge to serve healthier foodNutrition · 2 outlets
- 9FDA approves talazoparib with enzalutamide for certain metastatic prostate cancersDrugs and FDA · 1 outlet
- 10Carolina Infusion recalls compounded tirzepatide products nationwideDrug safety · 1 outlet